Posted by admin on Jul 30th, 2022
Stryker (NYSE:SYK – Get Rating) was upgraded by analysts at Edward Jones from a “hold” rating to a “buy” rating in a report issued on Thursday, MarketBeat Ratings reports.
Other research analysts have also issued reports about the stock. Piper Sandler lowered their price objective on shares of Stryker from $290.00 to $250.00 and set an “overweight” rating on the stock in a research note on Wednesday. TheStreet lowered shares of Stryker from a “b” rating to a “c+” rating in a research note on Monday, May 2nd. Stifel Nicolaus decreased their price target on shares of Stryker from $285.00 to $245.00 in a research note on Monday, July 18th. Cowen decreased their price target on shares of Stryker from $305.00 to $233.00 and set a “maintains” rating on the stock in a research note on Friday, July 22nd. Finally, Bank of America lowered shares of Stryker from a “buy” rating to a “neutral” rating in a research note on Monday, July 11th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $251.94.
Shares of NYSE:SYK opened at $214.75 on Thursday. The company’s 50-day moving average price is $209.39 and its two-hundred day moving average price is $239.02. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.98 and a quick ratio of 1.18. Stryker has a one year low of $188.84 and a one year high of $281.16. The stock has a market capitalization of $81.21 billion, a PE ratio of 40.83, a price-to-earnings-growth ratio of 2.34 and a beta of 1.04.
Stryker (NYSE:SYK – Get Rating) last released its quarterly earnings data on Tuesday, July 26th. The medical technology company reported $2.25 earnings per share for the quarter, missing the consensus estimate of $2.28 by ($0.03). Stryker had a return on equity of 24.09% and a net margin of 11.56%. During the same quarter last year, the business earned $2.25 EPS. On average, equities analysts forecast that Stryker will post 9.6 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in SYK. First Western Trust Bank bought a new position in Stryker in the 1st quarter valued at approximately $1,090,886,000. Norges Bank bought a new position in Stryker in the 4th quarter valued at approximately $816,519,000. Ontario Teachers Pension Plan Board lifted its stake in Stryker by 87,902.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 2,077,732 shares of the medical technology company’s stock valued at $555,482,000 after purchasing an additional 2,075,371 shares during the last quarter. Wellington Management Group LLP lifted its stake in Stryker by 11.3% in the 1st quarter. Wellington Management Group LLP now owns 15,370,391 shares of the medical technology company’s stock valued at $4,109,274,000 after purchasing an additional 1,561,376 shares during the last quarter. Finally, AustralianSuper Pty Ltd bought a new position in Stryker in the 1st quarter valued at approximately $295,397,000. Institutional investors own 74.52% of the company’s stock.
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
QUALCOMM (NASDAQ:QCOM) Upgraded to “Buy” by Edward Jones
Equities Analysts Issue Forecasts for Pentair plc’s Q4 2022 Earnings (NYSE:PNR)